Xcout Intel
BIOPHYTIS
Biophytis is a clinical-stage biotechnology company that develops transformational therapies to improve longevity and treat age-related diseases. The company utilizes an AI-driven research platform to discover novel drug candidates, with advanced clinical programs focusing on sarcopenia and obesity.
Subscribe to see BIOPHYTIS’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BIOPHYTIS at a glance
BIOPHYTIS is a biotech company headquartered in France. Xcout tracks 15 named people at BIOPHYTIS, including Edouard Bieth (Chief Strategy Officer).
BIOPHYTIS leadership
- Edouard BiethChief Strategy Officer
- Christophe CourtillatDirecteur administratif et financier
- Pr. Jean MarianiDirecteur médical
- Stanislas VeilletPrésident, Directeur général
- René LafontDirecteur Scientifique Co-fondateur
- Chiara BaccelliDirecteur des opérations pharmaceutiques et de l’assurance qualité
9 more named people on record for BIOPHYTIS, with roles, board committees and tenure — see the full roster →
BIOPHYTIS competitors
A few of BIOPHYTIS's closest competitors — see the full list of competitors and alternatives →
Adocia is a clinical-stage biotechnology company that develops innovative formulations of proteins, peptides, and metabolic hormones. The company specializes in creating treatments for diabetes and obesity, as well as immunoprotective scaffolds for cell therapies.
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to revolutionizing oral therapies for obesity and metabolic diseases.
AdipoPharma is a French biotech company dedicated to understanding the role of adipocyte cells in diabetes, focusing on lipid biosynthesis and whole-body metabolic health.
Autonomy Bio Inc. is a biotechnology company focused on developing human aging therapeutics aimed at extending healthspan and mitigating age-related decline. The company targets individuals seeking to maintain health and independence as they age.
Get BIOPHYTIS's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BIOPHYTIS in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access